Streetbeat News

Analyst Ratings

VIRT

Citigroup has reaffirmed its Buy rating on Virtu Financial Inc (NASDAQ:VIRT) but reduced its price target from $22.00 to $21.00. Virtu Financial's shares have risen 1.6% in the last 24 hours to $17.74. The new price target suggests an 18.38% upside potential. Virtu Financial is a market maker and liquidity provider, with the majority of its revenue coming from the United States.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 5:00 pm

NEP

JP Morgan has maintained a Neutral rating for NextEra Energy Partners (NEP) but raised its price target from $24.00 to $26.00. NEP shares are currently trading down at $28.84, which is above the new target. The company, which focuses on contracted clean energy projects and natural gas infrastructure, would see a 9.83% decline in share price if it reached the new target of $26.00.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 5:00 pm

APPF

AXP

CRBP

EHTH

INTC

PCSA

TKLF

American Express (NYSE:AXP) shares rose over 7% after reporting Q4 financial results and announcing plans to increase its dividend, despite missing revenue and EPS consensus. AppFolio (NASDAQ:APPF) shares surged 28% on strong Q4 results and guidance. Corbus Pharmaceuticals (NASDAQ:CRBP) soared 221% on positive clinical study data. eHealth (NASDAQ:EHTH) gained 24% on preliminary Q4 results. Intel (NASDAQ:INTC) fell 10% due to a weak Q1 forecast. Processa Pharmaceuticals (NASDAQ:PCSA) dropped 25% after announcing a public offering. Yoshitsu (NASDAQ:TKLF) plummeted 60% after a direct offering and private placement announcement. Crude oil was down 1%, while U.S. stocks traded higher overall.

Portfolio Pulse from Avi Kapoor

January 26, 2024 | 5:00 pm

TCBK

Keefe, Bruyette & Woods has maintained its Market Perform rating for TriCo Bancshares (NASDAQ:TCBK) but lowered its price target from $44.00 to $42.00. TriCo's shares are currently trading at $38.27, and the new price target suggests a potential upside of 9.75%. TriCo Bancshares operates as a bank holding company for Tri Counties Bank, offering various banking services primarily in California.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 5:00 pm

EXPI

DA Davidson has downgraded eXp World Holdings (NASDAQ:EXPI) from a previous rating to Neutral and reduced the price target from $20.00 to $15.00. Following the downgrade, EXPI shares have fallen 3.12% to $13.03. The new price target suggests a potential upside of 15.12% from the current price. eXp World Holdings is a cloud-based residential real estate company with operations in various countries.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 5:00 pm

BPOP

RBC Capital has reaffirmed its Outperform rating on Popular Inc (NASDAQ:BPOP) and increased its price target from $80.00 to $90.00. Popular's shares are currently trading at $85.83, and the new price target suggests a potential upside of 4.86%. Popular Inc is a financial holding company with significant operations in Puerto Rico and the continental United States.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 5:00 pm

KRTX

Mizuho has downgraded Karuna Therapeutics (NASDAQ:KRTX) to Neutral, adjusting the price target from $245.00 to $330.00. Despite the downgrade, the new price target suggests a potential upside of 5.05% from the current share price of $314.12. Karuna Therapeutics is a clinical-stage biopharmaceutical company developing therapies for neuropsychiatric conditions.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 5:00 pm

AAL

AMSC

DWAC

LVTX

VERA

Benzinga's Stock Whisper Index highlighted five stocks: AAL, DWAC, VERA, AMSC, and LVTX. AAL reported strong Q4 results, beating estimates and receiving analyst upgrades, with shares up 13% in five days. DWAC shares hit two-year highs after Trump's primary wins and DeSantis' endorsement, with a SPAC merger deadline extended to March 8, 2024. VERA shares soared after positive Phase 2b trial results, leading to analyst upgrades and a 95% weekly gain. AMSC reported a 60% YOY revenue increase in Q3 and strong demand for new energy power systems. LVTX shares rose 40% after announcing a clinical trial collaboration with MRK for a prostate cancer treatment.

Portfolio Pulse from Chris Katje

January 26, 2024 | 4:50 pm

INTC

Rosenblatt analyst Hans Mosesmann has reiterated a Sell rating on Intel Corporation (NASDAQ:INTC) and maintained a price target of $17.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 4:42 pm

CATX

B. Riley Securities analyst Yuan Zhi has initiated coverage on Perspective Therapeutics (AMEX:CATX) with a Buy rating and set a price target of $1.2.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 4:39 pm